CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Exact Sciences Corp  (EXAS)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
 
 

EXAS's Revenue Year on Year Growth by Quarter and Year

Exact Sciences's Revenue results by quarter and year



Select the Comparisons : Select the Ratio:                        
EXAS Revenue (in millions $) FY 2017 FY 2016 FY 2015 FY 2014
IV Quarter December - 99.38 14.42 1.50
III Quarter September - 28.12 12.63 -
II Quarter June - 21.19 8.12 -
I Quarter March 48.36 14.84 4.27 0.29
FY   48.36 163.53 39.44 1.79

Financial Statements
Exact Sciences's first quarter 2017 Revenue $ 48.36 millions EXAS's Income Statement
Exact Sciences's first quarter 2016 Revenue $ 14.84 millions Quarterly EXAS's Income Statement
EXAS's Growth by Division See EXAS's Growth by Segment

EXAS Revenue ( Y/Y Growth %) 2017
2016 2015 2014
IV Quarter December - 589.18 % 861.33 % 44.23 %
III Quarter September - 122.64 % - -
II Quarter June - 160.96 % - -
I Quarter March 225.9 % 247.54 % 1372.41 % -72.12 %
FY   - 314.63 % 2103.35 % -



EXAS Revenue Growth Comment
Exact Sciences Corp reported Revenue surge of 225.9% year on year in the first quarter, to $ 48.36 millions, this is lower than Exact Sciences Corp's recent average Revenue surge of 261.64%.

Looking into first quarter results within Medical Laboratories industry 5 other companies have achieved higher Revenue growth. While Exact Sciences Corp' s Revenue doubling of 225.9% ranks overall at the positon no. 106 in the first quarter.



Revenue Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #6
Healthcare Sector #31
S&P 500 #106
Revenue Y/Y Growth Statistics
High Average Low
1351.02 % 261.64 % -100 %
(Mar 31 2015)   (Sep 30 2014)

You need to upgrade your Flash Player

Other Revenue Growth
Medical Laboratories Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
EXAS's Revenue Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for EXAS's Competitors
Revenue Growth for Exact Sciences's Suppliers
Revenue Growth for EXAS's Customers

You may also want to know
EXAS's Annual Growth Rates EXAS's Profitability Ratios EXAS's Asset Turnover Ratio EXAS's Dividend Growth
EXAS's Roe EXAS's Valuation Ratios EXAS's Financial Strength Ratios EXAS's Dividend Payout Ratio
EXAS's Roa EXAS's Inventory Turnover Ratio EXAS's Growth Rates EXAS's Dividend Comparisons



Companies with similar Revenue doubling for the quarter ending Mar 31 2017 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2017
Sorrento Therapeutics, Inc.  393.32 %$ 393.320 millions
Bluebird Bio, Inc.  355.77 %$ 355.771 millions
Agenus Inc  352.36 %$ 352.365 millions
Protalix Biotherapeutics, Inc.  325.48 %$ 325.479 millions
Lifestyle Medical Network, Inc.  319.44 %$ 319.438 millions
Orexigen Therapeutics, Inc.  280.39 %$ 280.389 millions
Intellia Therapeutics, Inc.  249.75 %$ 249.747 millions
Biolargo, Inc.  230.06 %$ 230.060 millions
Corbus Pharmaceuticals Holdings, Inc.  226.20 %$ 226.199 millions
Exact Sciences Corp  226.01 %$ 226.006 millions
Accelerate Diagnostics, Inc.  225.15 %$ 225.153 millions
Ionis Pharmaceuticals Inc  199.14 %$ 199.138 millions
Immune Design Corp.  193.34 %$ 193.344 millions
Transgenomic Inc  178.81 %$ 178.814 millions
Icu Medical Inc  175.71 %$ 175.710 millions
Novocure Ltd  167.22 %$ 167.218 millions
Invitae Corp  161.39 %$ 161.391 millions
Eagle Pharmaceuticals, Inc.  159.51 %$ 159.515 millions
Alnylam Pharmaceuticals, Inc.  158.13 %$ 158.135 millions
Catasys, Inc.  150.27 %$ 150.275 millions
Catalyst Biosciences, Inc.  148.62 %$ 148.624 millions
Viveve Medical, Inc.  136.84 %$ 136.838 millions
Flex Pharma, Inc.  134.72 %$ 134.724 millions
China Longyi Group International Holdings Ltd  126.39 %$ 126.388 millions
Neos Therapeutics, Inc.  117.85 %$ 117.847 millions
Hemispherx Biopharma Inc  115.38 %$ 115.385 millions
Novabay Pharmaceuticals, Inc.  115.30 %$ 115.300 millions
Economy

Advance Monthly Sales
Consumer Price Index CPI
Producer Price Index PPI
Retail Inventories
Personal Income
Gross Domestic Product GDP
Money Supply
Industrial Production
Productivity
Employment Situation
US International Trade
Factory Orders
Durable Goods
Construction Spending
Housing Starts
Vehicle Unit Sales
Stocks

Event Calendar
BSPM's Profile
Stock Price
BSPM's Financials
BSPM's Expectations
Business Description
Fundamentals
Charts & Quotes
BSPM's News
Suppliers
BSPM's Competitors
Customers & Markets
Economic Indicators
BSPM's Growth
Company Segments
Industries

At a Glance
Performance
Growth Rates
Profitability
Valuation
Financial Strength
Markets

At a Glance
Stocks
Indices
Sectors & Industries
Financials
Commodities
Currencies
Screening

Stock Performance
Growth Rates
Profitability
Valuation
Dividend
Financial Strength
Efficiency
Expectations
Management Effectivness
News

At a Glance
Stocks
Economy
Industries
Other
Glossary

Financial Terms
Technical Analysis
Fundamental Analysis
Energy Terms
Manufacturing Terms
Transportation Terms
Health Care
Insurance Terms
Economy Terms
Hotel & Leisure Terms
Help

Sitemap
Advertise
About us
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com